CiteThis

CiteThis / tags

Short-Chain Fatty Acids (SCFAs)

#scfa

2 protocols

Quick Facts
  • • Primary SCFAs: acetate, propionate, butyrate
  • • Produced by: gut bacteria fermenting dietary fiber
  • • Key producers: Faecalibacterium, Roseburia, Bifidobacterium
  • • Brain effects: butyrate crosses BBB, modulates microglia
  • • Reduced in: ADHD, depression, inflammatory bowel disease

Short-chain fatty acids (SCFAs) are organic acids with fewer than six carbons produced when gut bacteria ferment dietary fiber and resistant starches. The three principal SCFAs are acetate, propionate, and butyrate, produced in approximately 60:20:20 molar ratio. Butyrate is the most studied because it serves as the primary energy source for colonocytes, maintains intestinal barrier integrity, exerts anti-inflammatory effects, and crosses the blood-brain barrier to modulate microglial activation and influence central nervous system function.

SCFAs represent a key pathway by which the gut microbiome affects distant organs including the brain. Key butyrate-producing bacteria include Faecalibacterium prausnitzii, Roseburia species, and Eubacterium rectale. Reduced abundance of these species, with correspondingly reduced SCFA production, is documented in ADHD adults (Ahrens et al., 2024 and subsequent studies), major depression, inflammatory bowel disease, and metabolic syndrome. The direction of causality is not always clear but mechanistic plausibility is strong: SCFAs regulate immune tone, intestinal permeability, and neurotransmitter signaling.

SCFA production depends more on dietary fiber diversity and quantity than on direct probiotic supplementation. Diets rich in fermentable fibers (resistant starches, beta-glucans from oats, inulin from chicory root, pectin from fruits) increase SCFA production within days to weeks. Meta-analyses show dietary interventions outperform probiotic supplementation for improving SCFA profiles. Direct butyrate supplementation (sodium butyrate or tributyrin) has limited human trial evidence but may support intestinal conditions. For mood and cognitive indications linked to SCFAs, dietary fiber diversity (aiming for 30+ different plant foods per week) is typically more effective than targeted supplementation.

Protocols

#adhd #gut-health #microbiome #probiotics #diet #mental-health

ADHD & Gut Health: Microbiome Protocol

Gut dysbiosis at age 1 precedes ADHD diagnosis by years — the first prospective evidence for a causal microbiome→ADHD pathway (Ahrens et al., 2024, n=16,440). Adults with ADHD show reduced SCFA-producing bacteria and elevated inflammatory species. Stimulant medications may further reduce microbial diversity. Probiotics show modest benefit in RCTs (SMD ~0.24), optimal duration 8 weeks. A healthy Mediterranean-style diet outperformed elimination diets in the largest trial (51% vs 35% improvement). Prioritize diet over supplements; probiotics are adjunctive.

20 sources 3/4 moderate Updated 2026-04-15
#gut-brain #probiotics #psychobiotics #anxiety #depression #microbiome #lactobacillus #bifidobacterium #omega-3 #inositol #vagus-nerve

Gut-Brain Axis: Evidence-Based Psychobiotic & Supplement Protocol

The gut-brain axis is a real, bidirectional communication system — but the psychobiotic field suffers from a critical strain-specificity problem: evidence for one strain cannot be extrapolated to another, even within the same species. The strongest human RCT evidence comes from L. rhamnosus HN001 (perinatal mood, OR 0.44), B. longum NCC3001 (IBS-related depression with fMRI confirmation), and multi-strain combinations. Omega-3 and inositol provide complementary mechanisms. This protocol layers interventions by evidence strength across 3 phases, with dietary change as the non-negotiable foundation.

7 sources 3/4 moderate Updated 2026-04-15

Related Topics

#microbiome #probiotics #adhd #gut-health #diet #mental-health